Ok..in this sea of red I was able to find one bright stock.
IMMU $2.268 +0.4476 (+24.59%)
Released news today: U.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast Cancer 9:28 AM ET 2/5/16 | GlobeNewswire Immunomedics, Inc., (Nasdaq:IMMU) today announced that its lead investigational antibody-drug conjugate, sacituzumab govitecan, or IMMU-132, has received Breakthrough Therapy Designation from the FDA for the treatment of patients with triple-negative breast cancer (TNBC) who have failed at least 2 prior therapies for metastatic disease.
The Breakthrough Therapy Designation was supported by a Phase 2 study in patients with metastatic TNBC who had received a median of 5 prior therapies (range, 2 - 12).
Here's the Daily Chart from StockCharts:
And Here's My Chart...150 Daily Candlesticks
IS THAT A HEAD AND SHOULDERS FORMING I SEE??? WHAT'S THE PLAY HERE???
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.